Eva Petermann
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 1%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
- Cancer therapeutics and mechanisms
Papers in
-
- DNA Repair Mechanisms 39
- CRISPR and Genetic Engineering 6
- Genomics and Chromatin Dynamics 5
- Ubiquitin and proteasome pathways 4
- Oncology 19
- Cancer-related Molecular Pathways 12
- PARP inhibition in cancer therapy 9
- Co-authors
- Thomas Helleday (12 shared papers)Ben Hodgson (1 shared paper)Cecilia Lundin (1 shared paper)Ricky A. Sharma (1 shared paper)Niklas Schultz (3 shared papers)Natalia Issaeva (2 shared papers)Keith W. Caldecott (5 shared papers)Panagiotis Kotsantis (5 shared papers)
- Journals
- Nature Communications (3 papers)Blood (3 papers)Nature Reviews Molecular Cell Biology (3 papers)The EMBO Journal (3 papers)Oncogene (2 papers)
- Partner nations
- United KingdomSwedenUnited States
In The Last Decade
Eva Petermann
50 papers receiving 6.3k citations
Eva Petermann's Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 2.6k
- Molecular Biology 5.4k
- Cancer Research 955
- Cell Biology 830
- Genetics 449
Countries citing papers authored by Eva Petermann
This map shows the geographic impact of Eva Petermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Petermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Petermann more than expected).
Fields of papers citing papers by Eva Petermann
This network shows the impact of papers produced by Eva Petermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Petermann. The network helps show where Eva Petermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Petermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA repair pathways as targets for cancer therapy Hit paper breakdown → | 2008 | 1383 |
| 2 | Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair Hit paper breakdown → | 2010 | 654 |
| 3 | 2009 | 491 | |
| 4 | 2006 | 295 | |
| 5 | 2010 | 285 | |
| 6 | 2018 | 268 | |
| 7 | Sources, resolution and physiological relevance of R-loops and RNA–DNA hybrids Hit paper breakdown → | 2022 | 242 |
| 8 | 2016 | 232 | |
| 9 | 2010 | 226 | |
| 10 | 2015 | 218 | |
| 11 | 2012 | 217 | |
| 12 | 2007 | 198 | |
| 13 | 2018 | 175 | |
| 14 | 2006 | 153 | |
| 15 | 2006 | 116 | |
| 16 | 2012 | 100 | |
| 17 | 2008 | 98 | |
| 18 | 2008 | 96 | |
| 19 | 2020 | 87 | |
| 20 | 2015 | 70 |
About Eva Petermann
Eva Petermann is a scholar working on Molecular Biology, Oncology, Cell Biology, Cancer Research and Plant Science, having authored 51 papers that have together received 6.4k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (39 papers), Microtubule and mitosis dynamics (12 papers), Cancer-related Molecular Pathways (12 papers), PARP inhibition in cancer therapy (9 papers), Carcinogens and Genotoxicity Assessment (7 papers), CRISPR and Genetic Engineering (6 papers), Genomics and Chromatin Dynamics (5 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Oncology (2.6k citations), Molecular Biology (5.4k citations), Cancer Research (955 citations), Cell Biology (830 citations) and Genetics (449 citations). Eva Petermann has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Thomas Helleday, Ben Hodgson, Cecilia Lundin, Ricky A. Sharma, Niklas Schultz, Natalia Issaeva, Keith W. Caldecott, Panagiotis Kotsantis, Rebecca M. Jones and Manuel Luís Orta. Their work appears in journals such as Nature Communications, Blood, Nature Reviews Molecular Cell Biology, The EMBO Journal and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.